{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-06-09",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20171114",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "application_docs": [
            {
              "id": "50414",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761070s000lbl.pdf",
              "date": "20171115",
              "type": "Label"
            },
            {
              "id": "50424",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/761070Orig1s000ltr.pdf",
              "date": "20171115",
              "type": "Letter"
            },
            {
              "id": "50943",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/761070Orig1s000TOC.html",
              "date": "20171229",
              "type": "Review"
            },
            {
              "id": "51888",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/217_761070 benralizumab clinical prea.pdf",
              "date": "19000101",
              "type": "Pediatric Medical Review"
            },
            {
              "id": "51889",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/216_761070  benralizumab clinpharm prea.pdf",
              "date": "19000101",
              "type": "Pediatric Clinical Pharmacology Review"
            },
            {
              "id": "51890",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/218_761070 benralizumab statistical prea.pdf",
              "date": "19000101",
              "type": "Pediatric Statistical Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "20",
          "submission_status": "AP",
          "submission_status_date": "20240405",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "78078",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761070Orig1s020correctedlbl.pdf",
              "date": "20240409",
              "type": "Label"
            },
            {
              "id": "78082",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/761070Orig1s020correctedltr.pdf",
              "date": "20240408",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "5",
          "submission_status": "AP",
          "submission_status_date": "20191003",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "60222",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761070s005lbl.pdf",
              "date": "20191004",
              "type": "Label"
            },
            {
              "id": "60244",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/761070Orig1s005ltr.pdf",
              "date": "20191004",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "23",
          "submission_status": "AP",
          "submission_status_date": "20260513",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "86148",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/761070Orig1s023correctedltr.pdf",
              "date": "20260605",
              "type": "Letter"
            },
            {
              "id": "86177",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761070s023lbl.pdf",
              "date": "20260608",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "21",
          "submission_status": "AP",
          "submission_status_date": "20240917",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "79652",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761070s021lbl.pdf",
              "date": "20240918",
              "type": "Label"
            },
            {
              "id": "79659",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/761070Orig1s0021ltr.pdf",
              "date": "20240919",
              "type": "Letter"
            }
          ]
        }
      ],
      "application_number": "BLA761070",
      "sponsor_name": "ASTRAZENECA AB",
      "openfda": {
        "application_number": [
          "BLA761070"
        ],
        "brand_name": [
          "FASENRA"
        ],
        "generic_name": [
          "BENRALIZUMAB"
        ],
        "manufacturer_name": [
          "AstraZeneca Pharmaceuticals LP"
        ],
        "product_ndc": [
          "0310-1730",
          "0310-1830",
          "0310-1745"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "SUBCUTANEOUS"
        ],
        "substance_name": [
          "BENRALIZUMAB"
        ],
        "rxcui": [
          "1989104",
          "1989109",
          "2205632",
          "2205634",
          "2679499",
          "2679502"
        ],
        "spl_id": [
          "b78fbf2b-888c-41e2-bdab-cb5cd1ebb8fe"
        ],
        "spl_set_id": [
          "da6aca1a-19ed-44a4-abb7-696c7d58b784"
        ],
        "package_ndc": [
          "0310-1730-30",
          "0310-1730-85",
          "0310-1830-30",
          "0310-1830-85",
          "0310-1745-01",
          "0310-1745-95"
        ],
        "nui": [
          "N0000193803",
          "N0000193802"
        ],
        "pharm_class_epc": [
          "Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]"
        ],
        "pharm_class_moa": [
          "Interleukin 5 Receptor alpha-directed Antibody Interactions [MoA]"
        ],
        "unii": [
          "71492GE1FX"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "TBD",
          "brand_name": "FASENRA",
          "active_ingredients": [
            {
              "name": "BENRALIZUMAB",
              "strength": "30MG/ML"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "INJECTABLE",
          "route": "INJECTION",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}